Guy is an original member of CNBC's Fast Money. He is currently the Director of Advisor Advocacy at Private Advisor Group in Morristown, New Jersey. Private Advisor Group is comprised of a network of nearly 500 advisors with assets approaching $16B.
Guy has held numerous key leadership roles in the financial services industry. He began his career at Drexel Burnham Lambert in 1986 and was quickly promoted to Vice President and Head Gold Trader at the firm. He then joined Goldman Sachs in 1996 as the head gold trader and one of the many proprietary traders within the Fixed Income Currency and Commodity division. In the spring of 2000, Adami joined the U.S. Equities division of Goldman Sachs where he was put in charge of the firm's Industrial/Basic Material group.
Guy is the Vice Chairman of the NJ Chapter of The Leukemia and Lymphoma Society and is a graduate of Georgetown University. He is also a board member of Invest in Others. In August 2012, Guy completed the New York City Ironman.
Follow Guy Adami on Twitter: @GuyAdami
CNBC contributor Jon Najarian, and Bob Doll, Nuveen Asset Management, team up with FM traders Karen Finerman, Guy Adami, and Dan Nathan to discuss the best way to play eBay ahead of Carl Icahn's appearance at Delivering Alpha.
Six stocks, one winner. Who will be crowned champion? Reggie Middleton, BoomBustBlog.com; Guy Adami StockMonster.com; Jeff Kilburg, KKM Financial; Abigail Doolittle, Peak Theories; and Josh Brown, Ritholtz Wealth Management, reveal the stock draft winner.
BUTY call! Miley 10 years from now, and The Shawshank just got redemption. It's time for "Something Completely Different."
Here’s our Fast Money Final Trade. The Fast gives you tomorrow’s best trades, right now.
Evercore ISI’s Mark Schoenebaum couldn't believe the Alexion and Synageva deal.
U.S. stocks closed lower, reversing a positive open, as investors weighed higher yields and energy prices ahead of Friday's important jobs report.
Halftime's hottest trades today: 6 trades in 35 seconds. Making moves on the Fed, interest rates, biotech, oil's spike, and VXX.